| Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study X Li, C Mukandavire, ZM Cucunubá, SE Londono, K Abbas, HE Clapham, ... The Lancet 397 (10272), 398-408, 2021 | 243 | 2021 |
| The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high … R Acevedo, X Bai, R Borrow, DA Caugant, J Carlos, M Ceyhan, ... Expert review of vaccines 18 (1), 15-30, 2019 | 201 | 2019 |
| Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world J Toor, S Echeverria-Londono, X Li, K Abbas, ED Carter, HE Clapham, ... Elife 10, e67635, 2021 | 87 | 2021 |
| Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries KAM Gaythorpe, K Abbas, J Huber, A Karachaliou, N Thakkar, K Woodruff, ... Elife 10, e67023, 2021 | 81 | 2021 |
| Modeling long-term vaccination strategies with MenAfriVac in the African meningitis belt A Karachaliou, AJK Conlan, MP Preziosi, CL Trotter Clinical Infectious Diseases 61 (suppl_5), S594-S600, 2015 | 76 | 2015 |
| Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis LV Cooper, PA Kristiansen, H Christensen, A Karachaliou, CL Trotter Epidemiology & Infection 147, e228, 2019 | 34 | 2019 |
| Household transmission of Neisseria meningitidis in the African meningitis belt: a longitudinal cohort study O Ali, A Aseffa, AB Omer, T Lema, TM Demissie, Y Tekletsion, A Worku, ... The Lancet global health 4 (12), e989-e995, 2016 | 34 | 2016 |
| Costs of Neisseria meningitidis Group A Disease and Economic Impact of Vaccination in Burkina Faso A Colombini, C Trotter, Y Madrid, A Karachaliou, MP Preziosi Clinical Infectious Diseases 61 (suppl_5), S473-S482, 2015 | 14 | 2015 |
| Vaccine impact modelling consortium, estimating the health impact of vaccination against 10 pathogens in 98 low and middle income countries from 2000 to 2030 X Li, C Mukandavire, ZM Cucunubá, K Abbas, HE Clapham, M Jit, ... Lancet 397, P398-P408, 2019 | 8 | 2019 |
| VIMC Working Group on COVID-19 Impact on Vaccine Preventable Disease, Ferrari M, Jackson ML, McCarthy K, Perkins TA, Trotter C, Jit M. Impact of COVID-19-related disruptions to … KAM Gaythorpe, K Abbas, J Huber, A Karachaliou, N Thakkar, K Woodruff, ... Elife 10 (10.7554), 2021 | 7 | 2021 |
| Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study AM Hartner, X Li, S Echeverria-Londono, J Roth, K Abbas, M Auzenbergs, ... The Lancet Global Health 12 (4), e563-e571, 2024 | 6 | 2024 |
| Understanding the role of duration of vaccine protection with MenAfriVac: simulating alternative vaccination strategies A Karachaliou Prasinou, AJK Conlan, CL Trotter Microorganisms 9 (2), 461, 2021 | 5 | 2021 |
| Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal carriage and disease in the UK L Hadley, AK Prasinou, H Christensen, M Ramsay, C Trotter Epidemiology & Infection 151, e98, 2023 | 3 | 2023 |
| Health impact of routine immunisation service disruptions and mass vaccination campaign suspensions caused by the COVID-19 pandemic: multimodel comparative analysis of … K Gaythorpe, K Abbas, J Huber, A Karachaliou, N Thakkar, K Woodruff, ... medRxiv, 2021.01. 25.21250489, 2021 | 3 | 2021 |
| Covid-19 Related Immunisation Disruptions from 2020-2030: Projecting Health Impact and Mitigation Strategies for 14 Pathogens Across 112 Low-and Middle-Income Countries AM Hartner, X Li, S Echeverria-Londono, J Roth, K Abbas, M Auzenbergs, ... | 1 | 2023 |
| Estimating the Potential Number of Cases Prevented by Infant/Toddler Immunisation with a MenaACWY Vaccine L Adams, A Karachaliou Prasinou, C Trotter, ME Ramsay, H Campbell Toddler Immunisation with a MenaACWY Vaccine, 2022 | 1 | 2022 |
| The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high … R Acevedo, X Bai, R Borrow, DA Caugant, J Carlos, M Ceyhan, ... EXPERT REVIEW OF VACCINES 21 (12), 1933-1933, 2022 | | 2022 |
| Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study A Winter, A Clark, A Karachaliou, CL Trotter, C Mukandavire, ... University of Notre Dame, 2021 | | 2021 |
| Using mathematical models to evaluate and inform immunisation strategies with MenAfriVac in the African meningitis belt A Karachaliou Prasinou | | 2020 |
| Global Meningococcal Initiative 2018: Current situation of meningococcal disease and further recommendations/strategies E Dinleyici, R Borrow, MK Taha, M Safadi, J Vazquez, V Smith, ... 2018 INTERNATIONAL PATHOGENIC NEISSERIA CONFERENCE, 138-138, 2018 | | 2018 |